Inventurus Knowledge Solutions Limited has informed the Exchange about Investor Presentation
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IKS Health has announced a definitive agreement to acquire 100% of TruBridge Inc. for an enterprise value of $557 million (equity $427M + debt $130M), taking the US-listed company private. The acquisition will be funded through approximately $600 million of debt at SOFR+275 bps. TruBridge is a fully integrated Revenue Cycle Management (RCM) and Electronic Health Record (EHR) vendor serving mid-small and rural hospitals, with $221M revenue, ~3,700 employees, and ~1,500 clients. Post-acquisition proforma combined revenue is $698M with adjusted EBITDA of $186M. The deal is expected to be PAT and EPS accretive in FY27 with incremental EBITDA adequate to cover interest and amortization costs. IKS targets FY2030 revenue of ~₹3,000 Crores and EBITDA of ~₹1,000 Crores, leveraging ~$575M cross-sell white space in TruBridge's client base.
This acquisition significantly expands IKS Health's addressable market into rural hospital EHR and acute RCM, creating a combined entity with ~17,000 employees and 2,000+ clients. The deal is funded by debt at ~3X leverage, with management guiding margin improvement to 30%+ combined EBITDA within 4 quarters. Shareholders should monitor integration execution and debt servicing given the leveraged buyout structure.